Topic
Cellular senescence
Everything we've written on Cellular senescence — 8 articles covering the mechanism, the evidence, comparisons, and practical considerations.
8 articles
Anti-aging and cellular healthCellular senescence in deeper detail — the biology, biomarkers, and intervention frontierA cell under severe stress faces a choice. It can repair the damage and carry on. It can trigger apoptosis — the orderly self-destruction program that eliminates compromised cells cleanly. Or it can do something else: it can stop dividing, enlarge, change its behavior, and stay. This third option is cellular senescence, and for decades it was understood primarily as a tumor suppression mechanism — a way of permanently halting cells that might otherwise accumulate mutations and turn cancerous. That understanding was correct as far as it went. What took longer to recognize was the cost.12 min readImmune modulationThe cGAS-STING pathway — DNA in the wrong place and the inflammaging it triggersIn 2013, Zhijian "James" Chen's lab at UT Southwestern had a specific problem to solve. The innate immune system was known to respond vigorously to cytoplasmic DNA — DNA found floating in the cell's interior, outside the nucleus where it belongs — and this response was central to how cells defend against DNA viruses. But no one had identified the cytoplasmic sensor doing the detecting. There were candidate molecules. None had been confirmed. Chen's lab designed a biochemical reconstitution assay to find it, purifying the sensor from cells by tracking which fractions could trigger the known downstream response, and in the process identified an enzyme that, when it bound double-stranded DNA, produced a small signaling molecule: cyclic GMP-AMP, or cGAMP. The enzyme was cGAS — cyclic GMP-AMP synthase. The downstream receptor for cGAMP was already known: STING, the stimulator of interferon genes. The discovery completed a circuit that had been understood only in pieces, and it opened a window into one of the most consequential inflammatory pathways in aging biology.11 min readAnti-aging and cellular healthExosomes and extracellular vesicles — the cell-to-cell communication system you didn't learn aboutIn 1983, two separate research groups — one in Montreal, one in Boston — were studying how developing red blood cells dispose of their transferrin receptors as they mature. The cell needed to get rid of certain surface proteins. They watched it do something unexpected: instead of simply degrading the receptors, the cell packaged them into tiny membrane-bound bubbles and released them into the surrounding fluid. The bubbles were assumed to be waste. Cellular garbage bags. The researchers noted the finding, named the vesicles, and moved on. Nobody thought this was a communication system. Nobody thought it was going to matter.12 min readAnti-aging and cellular healthFOXO4-DRI — the senolytic peptide that started the conversationIn the spring of 2017, a paper appeared in the journal Cell that produced an unusual reaction in the longevity research community — a reaction that was part scientific excitement, part careful skepticism, and part something rarer in academic biology: the sense that a mechanism had been found that was genuinely elegant. The paper came from Peter de Keizer and colleagues at Erasmus University Medical Center in Rotterdam. The compound at the center of it was a synthetic peptide called FOXO4-DRI. The images that accompanied the paper — aged mice that had regrown their fur, restored their kidney function, run faster, recovered what looked like younger vitality after treatment — circulated widely online in a way that peer-reviewed biology papers almost never do.8 min readAnti-aging and cellular healthThe Hayflick limit and telomerase — why cells stop dividing, and why that's complicatedIn the late 1950s, the prevailing belief among cell biologists was that cells grown in culture were, in principle, immortal. The authority for that view was Alexis Carrel, a Nobel laureate who claimed to have kept a culture of chick heart cells dividing continuously for decades — long past the lifespan of any chicken. The conclusion drawn from Carrel's famous experiment was that cells did not age; only the organism did, and any limit on a cell's lifespan in a dish must be a failure of technique. Then a young anatomist named Leonard Hayflick, working at the Wistar Institute in Philadelphia, started paying close attention to his own cultures of human fibroblasts and noticed something Carrel's dogma did not predict. The cells divided vigorously, then slowed, then stopped. Every time. No matter how perfect the culture conditions.8 min readImmune modulationInflammaging — the chronic low-grade inflammation that drives agingIn 2000, an Italian immunologist named Claudio Franceschi published a paper that changed how aging biology thinks about its central problem. Franceschi had spent years studying centenarians — people who had reached one hundred years and beyond — and what he noticed was not just that they had survived to an unusual age, but how their immune systems were different. They had elevated inflammatory markers. Their baseline levels of IL-6, TNF-α, and CRP — the circulating proteins that signal tissue inflammation — were higher than younger adults. And yet they were extraordinarily healthy. They had reconciled, somehow, with an inflammatory burden that in most people would be associated with disease.7 min readAnti-aging and cellular healthThe senescent cell story — what makes cells 'zombie cells'You cut your hand and it heals. The skin closes, the inflammation resolves, the scar fades over months. At no point do you consciously manage this — your body runs an intricate repair sequence without your input, and if you're young and healthy, the outcome is essentially complete restoration. What you don't see is the cellular machinery underneath that sequence: cells dividing to replace damaged ones, immune cells clearing debris, signaling molecules coordinating the whole operation with timing measured in hours. And somewhere in that process, certain cells that have served their purpose — that have divided as many times as they safely can, or that have accumulated damage that makes further division risky — enter a state from which they will not emerge. They stop dividing and stay stopped. They are still alive. They will not come back.8 min readAnti-aging and cellular healthTelomere biology and aging — what Elizabeth Blackburn's discovery means for youIn 2009, Elizabeth Blackburn, Carol Greider, and Jack Szostak shared the Nobel Prize in Physiology or Medicine for their discovery of how chromosomes are protected by telomeres and the enzyme telomerase. The prize validated decades of work that had started in an unlikely place: the single-celled pond organism Tetrahymena, which Blackburn and Szostak used to identify the repetitive DNA sequences capping chromosome ends, and which Blackburn and Greider then used to discover the enzyme responsible for maintaining them. The Nobel committee was recognizing work that had already reshaped cell biology. What they were also recognizing, by extension, was a molecular framework for understanding one of the most important questions in aging research: why do cells stop dividing?9 min read